Events and Presentations Presentations Documents January 2024 Corporate Presentation Clinical And Biological Activity Of FLX475, An Oral CCR4 Antagonist, In Combination With Pembrolizumab In Advanced Cancer, CICON 2023 Clinical and Biological Activity of FLX475, an Oral CCR4 Antagonist, in Advanced Cancer, ASCO 2023 FLX475 SITC Conference Call Slides Upcoming Events There are no upcoming events available at this time.